Tuesday, February 27, 2024 9:20:50 AM
https://www.accesswire.com/836529/catheter-precision-inc-nys-american-vtak-announces-attendance-at-the-international-symposium-on-left-atrial-appendage
FORT MILL, SC / ACCESSWIRE / February 26, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based medical device company focused on novel electrophysiology products, announced that the Company is showcasing their LockeT suture closure device at the International Symposium on Left Atrial Appendage. The annual ISLAA conference is taking place at the Intercontinental New York Times Square in New York City from March 1 - 2, 2024.
Catheter Precision's CEO, David Jenkins, said, "Last week VTAK announced that the initial clinical data on LockeT was shared at the Western Atrial Fibrillation Symposium with great response from physicians and industry. Last week's meeting focused on advancements in Atrial Fibrillation, but this ISLAA will focus on the Left Atrial Appendage (LAA) and expands the audience to all cardiovascular physicians. LockeT's use in LAA procedures enables the benefits of our closure device to go beyond electrophysiology procedures."
The ISLAA conference is an internationally recognized meeting focused on educating physicians, nurses and allied health professionals in the fields of electrophysiology, cardiology, family and internal medicine about the Left Atrial Appendage (LAA). Educational sessions are led by world-renowned faculty and the symposium will offer very informative presentations on the anatomy, physiology and pathological aspect of the LAA, along with old and new therapeutic strategies of stroke prophylaxis including cardiac devices for LAA exclusion.
Recent RMED News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 08:20:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 08:16:48 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:15:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:19:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 08:16:05 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/20/2023 08:26:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 08:15:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:15:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM